Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells

An activated AKT pathway underlies the pathogenesis of soft tissue sarcoma (STS), with over-expressed phosphorylated AKT (p-AKT) correlating with a poor prognosis in a subset of STS cases. Recently, eribulin, a microtubule dynamics inhibitor, has demonstrated efficacy and is approved in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayasaka, Naotaka, Takada, Kohichi, Nakamura, Hajime, Arihara, Yohei, Kawano, Yutaka, Osuga, Takahiro, Murase, Kazuyuki, Kikuchi, Shohei, Iyama, Satoshi, Emori, Makoto, Sugita, Shintaro, Hasegawa, Tadashi, Takasawa, Akira, Miyanishi, Koji, Kobune, Masayoshi, Kato, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453888/
https://www.ncbi.nlm.nih.gov/pubmed/30962488
http://dx.doi.org/10.1038/s41598-019-42300-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453888/
https://www.ncbi.nlm.nih.gov/pubmed/30962488
http://dx.doi.org/10.1038/s41598-019-42300-z

Ejemplares similares